Related Experiment Video

Updated: Jun 1, 2026

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Emerging therapies for the treatment of neovascular age related macular degeneration

Alex Yuan1, Peter K Kaiser

  • 1Cole Eye Institute, Cleveland, OH 44195, USA.

Seminars in Ophthalmology
|May 26, 2011
PubMed

Insights

New drugs targeting the vascular endothelial growth factor pathway and other angiogenesis targets are in early clinical trials for neovascular age-related macular degeneration. This review discusses their mechanisms and early trial results.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Pharmacology

Background:

  • Neovascular age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Angiogenesis, the formation of new blood vessels, plays a critical role in AMD pathogenesis.
  • Current treatments aim to inhibit aberrant blood vessel growth.

Purpose of the Study:

  • To review the current landscape of novel therapeutics for neovascular AMD.
  • To discuss drugs targeting the vascular endothelial growth factor (VEGF) pathway and other angiogenesis mechanisms.
  • To summarize findings from early clinical trials of these emerging treatments.

Main Methods:

  • Review of scientific literature on angiogenesis and AMD.
  • Analysis of data from early-phase clinical trials of novel anti-angiogenic drugs.
  • Discussion of the mechanisms of action for various therapeutic candidates.

Main Results:

  • Several novel drugs targeting VEGF and other angiogenesis pathways are in development.
  • Early clinical trials are evaluating the safety and efficacy of these agents.
  • Promising results suggest potential for improved treatment outcomes in neovascular AMD.

Conclusions:

  • Novel therapeutic strategies targeting angiogenesis show promise for neovascular AMD.
  • Further clinical investigation is required to establish the role of these drugs in patient care.
  • Understanding drug mechanisms and trial outcomes is crucial for advancing AMD treatment.

More Related Videos

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.